
Alto Neuroscience
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -184 | -157 | ||
EBITDA | -23,450 | -26,963 | -25,508 | -15,450 |
EBIT | -24,661 | -27,147 | -25,692 | -15,607 |
Net Income | -25,124 | -27,638 | -26,237 | -16,182 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -20,756 | -19,760 | -27,647 | -11,516 |
Cash | 319,344 | 243,733 | 263,762 | 176,484 |
Basic Shares | 46,531 | 42,813 | 32,893 | 31,923 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -661 | -502 | -373 | -342 |
EBITDA | -60,108 | -62,304 | -34,562 | -27,368 |
EBIT | -60,769 | -62,806 | -34,935 | -27,710 |
Net Income | -63,238 | -61,431 | -36,305 | -27,710 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -51,793 | -49,499 | -33,918 | -21,126 |
Cash | 176,484 | 168,229 | 82,548 | 48,344 |
Basic Shares | 28,852 | 24,602 | 26,883 | 25,574 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.54 |
2026-06-30 | -$0.65 |
2026-03-31 | -$0.80 |
2025-12-31 | -$0.45 |